BridgeBio Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Monday, February 8, 2021 1 min read

Key Takeaway: BridgeBio Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)